The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study

Balloon Dilatation Catheter for the Dilation of Stenotic Atherosclerotic Lesions in Coronary Artery or Bypass Grafts: Evaluation of Safety and Performance in Everyday Clinical Practice. The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study

The aim of the present observational study is to collect clinical data on the non-implantable medical device INVADER™ PTCA in the daily use in an unselected population.

Inclusion Criteria:

• To be a Turkish citizen,
• To be >18 years of age,
• Lesion must be successfully crossed with a guidewire without complication,
• INVADER™ PTCA is used in the primary lesion treated during the procedure,
• Patient has signed and dated the informed consent.

Exclusion Criteria:

• Patients who have a known allergic reaction to any of the composition of INVADER™ PTCA Balloon Dilatation Catheter.
• Device use not consistent with Instructions for Use (IFU).
• Patients concurrently participating in another medical device or pharmaceutical clinical trial.